Swiss drugmaker Roche Holding AG (ROG.S) said on Thursday it would buy the rest of U.S. cancer data company Flatiron Health for $1.9 billion to speed development of cancer medicines and support its efforts to price them based on how well they work.
{iframe}https://www.reuters.com/article/us-flatiron-health-m-a-roche-hldg/roche-to-buy-flatiron-health-for-1-9-billion-to-expand-cancer-care-portfolio-idUSKCN1FZ2R0{/iframe}